EP0920864A1 — Combination therapy including a specific beta-3 agonist and an anorectic agent
Assigned to Pfizer Products Inc · Expires 1999-06-09 · 27y expired
What this patent protects
This invention relates to pharmaceutical compositions and methods which have utility in treating obesity in animals and particularly in humans. The invention is particularly directed to such compositions which comprise a mixture of a compound which modifies eating behavior and (4…
USPTO Abstract
This invention relates to pharmaceutical compositions and methods which have utility in treating obesity in animals and particularly in humans. The invention is particularly directed to such compositions which comprise a mixture of a compound which modifies eating behavior and (4-(2-(2-(6-aminopyridin-3-yl)-2(R)-hydroxyethylamino)ethoxy)phenyl)acetic acid, which is the compound of Formula I:
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.